Publications
113
Citations
2,290
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
Quintin Pan's research focuses on head and neck cancers, particularly those associated with HPV (human papillomavirus) infection. Recent work includes studying drug compounds (p300 bromodomain inhibitors) that may slow cancer cell growth by triggering cell senescence, and developing clinical laboratory tests to help guide treatment decisions for patients with HPV-associated head and neck cancer.
Publication output has grown substantially over the last decade, rising from little to no output in 2017-2018 to a notable surge in 2023 and 2026, indicating an increasingly active and growing research output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 7063: p300 bromodomain inhibitors impair cell proliferation by inducing senescence in HPV positive head and neck squamous cell carcinoma.
Cancer Research · 2026
- Supplementary Figure S2 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S3 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Data S1 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S4 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Table S4 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S5 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S8 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S9 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Table S3 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S1 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Table S2 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Table S1 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Data from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Supplementary Figure S7 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
2026
- Oral Oncology×3
- Frontiers in Oncology×2
- American Journal of Otolaryngology×2
- Cancers×2
- Oral Surgery Oral Medicine Oral Pathology and Oral Radiology×2
- Taylor Freeman
Medicine · The Ohio State University
- Zhen-yue Tong
Medicine · The Ohio State University
- Yingshi Guo
Medicine · The Ohio State University
- Priyanka Bhateja
Medicine · The Ohio State University
- James W. Rocco
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile